Litaba

Ka la 12 Hlakubele^th 2022, theNMPA (SFDA) e fane ka tsebiso e amohelang phetoho ea kopo ea ho itlhahloba ka lihlahisoa tsa antigen tsa COVID-19 ke Nanjing Vazyme BiotechCo., Ltd, Beijing Jinwofu Bioengineering TechnologyCo., Ltd, Shenzhen Huada Yinyuan Pharmaceutical Technology Co., Ltd, Guangzhou Wondfo Biotech Co., Ltd leBeijing Savant Biotechnology Co., Ltd(Huaketai). Lihlahisoa tse hlano tsa ho itlhahloba ka li-antigen tsa COVID-19 li se li hlahisitsoe.

Ka la 11 Hlakubele 2022, NHC e phatlalalitse hore, molemong oa ho ntlafatsa leano la tlhahlobo ea Novel Coronavirus le ho sebeletsa litlhoko tsa thibelo le taolo ea COVID-19, Sehlopha se Akaretsang sa Ts'ebetso e Kopanetsoeng ea Thibelo le taolo ea Lekhotla la Naha e nkile qeto ea ho eketsa. tlhahlobo ea antigen ho etsa tlhahlobo ea nucleic acid le ho etsa "Protocol ea Kopo ea Novel Coronavirus Antigen Detection (Trial)"
Protocol e totobatsa palo ea batho ba sebetsang bakeng sa tlhahlobo ea antigen:
Ntlha ea pele, ba etelang litsi tsa mantlha tsa bongaka 'me ba e-na le matšoao a kang mokhoa oa ho hema le feberu nakong ea matsatsi a 5 ho qala ha matšoao;
Taba ea bobeli, basebetsi ba hlokomelang batho ba behelletsoeng ka thoko, ho kenyeletsoa tlhokomeliso ea ho behelloa ka thoko malapeng, ho ba le kamano e haufi-ufi le ho ikopanya le batho ba haufi-ufi, ho shebella batho ba behelletsoeng ka thoko, sebaka sa polokelo le basebetsi ba sebaka sa taolo;
Ea boraro ke baahi ba sechaba ba nang le tlhoko ea ho itlhahloba ka antigen.

Malebela: Ho lemoha ha antigen ke tlatsetso ea bohlokoa ea ho lemoha ha nucleic acid, empa liphetho tsa ho itlhahloba ha antigen li ke ke tsa sebelisoa e le motheo oa tlhahlobo ea tšoaetso.